These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10884062)

  • 1. 18-MC reduces methamphetamine and nicotine self-administration in rats.
    Glick SD; Maisonneuve IM; Dickinson HA
    Neuroreport; 2000 Jun; 11(9):2013-5. PubMed ID: 10884062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.
    Glick SD; Sell EM; McCallum SE; Maisonneuve IM
    Eur J Pharmacol; 2011 Nov; 669(1-3):71-5. PubMed ID: 21871879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
    Maisonneuve IM; Glick SD
    Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.
    Glick SD; Sell EM; Maisonneuve IM
    Eur J Pharmacol; 2008 Dec; 599(1-3):91-5. PubMed ID: 18930043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.
    Szumlinski KK; Balogun MY; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):234-41. PubMed ID: 10972470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats.
    Rezvani AH; Cauley MC; Slade S; Wells C; Glick S; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2016; 150-151():153-157. PubMed ID: 27984095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.
    Glick SD; Ramirez RL; Livi JM; Maisonneuve IM
    Eur J Pharmacol; 2006 May; 537(1-3):94-8. PubMed ID: 16626688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.
    Glick SD; Maisonneuve IM; Kitchen BA; Fleck MW
    Eur J Pharmacol; 2002 Mar; 438(1-2):99-105. PubMed ID: 11906717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats.
    Glick SD; Maisonneuve IM; Dickinson HA; Kitchen BA
    Eur J Pharmacol; 2001 Jun; 422(1-3):87-90. PubMed ID: 11430918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bupropion on nicotine self-administration in rats.
    Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.
    Pace CJ; Glick SD; Maisonneuve IM; He LW; Jokiel PA; Kuehne ME; Fleck MW
    Eur J Pharmacol; 2004 May; 492(2-3):159-67. PubMed ID: 15178360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
    Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.